Aster DM Healthcare affirms its contribution to India’s growing medical value tourism

Dr Azad Moopen, Founder Chairman and MD of Aster DM, attends CEO Roundtable Session and Co-chairs session on the Continuum of Integrated Healthcare at the 7th Edition of Advantage Health Care-India 2023

Aster DM Healthcare played a pivotal role in the recently concluded 7th Edition of the Advantage Health Care-India summit, themed ‘ONE EARTH ONE HEALTH.’ The event, held at the Mahatma Mandir Convention & Exhibition Centre in Gandhinagar, Gujarat, was jointly organised by the Ministry of Health & Family Welfare (MoH&FW), Government of India, and the Federation of Indian Chambers of Commerce & Industry (FICCI). The summit coincided with the G20 4th Health Working Group & Ministers Meeting, providing an unprecedented platform for global healthcare leaders to converge and chart the course for the future of medical tourism.

Dr Azad Moopen, Founder Chairman and MD, Aster DM Healthcare in his inaugural speech at Advantage Health Care-India 2023, said, “Today the image of India has completely transformed, especially in healthcare. India has the advantage of providing comprehensive care with access to traditional medicine and modern medical treatment. If earlier the advantage of Medical Value Tourism in India was the cost differentiator, today we are known for the quality of medical care through tertiary and quaternary treatment. With more than 42 JCI-accredited hospitals and thousands of NABH-accredited hospitals across the nation, India today is at the top when it comes to quality care. With the participation or health ministers and officials from 70 countries, Advantage Health Care-India 2023 will add immense value in nurturing partnerships in the growing MVT sector in India. We at Aster DM Healthcare are open to providing facilities for training as well as cooperating with neighbouring countries to provide the best medical care.”

The Medical Value Tourism (MVT) industry in India is experiencing remarkable growth, presenting lucrative opportunities for private companies. As of 2020, the MVT market in India was valued at $2.89 billion, with projections indicating a substantial increase to reach $13.42 billion by 2026. This rapid expansion underscores the immense potential for enterprises to establish a strong presence within this thriving sector.
Regarding Aster’s participation at the Advantage Health Care-India summit, Dr Moopen, said, “The future of healthcare lies in the seamless integration of medical excellence, technology, and collaboration. India offers a wide range of medical treatments, including modern and traditional medicine, making it a one-stop destination for medical needs. With the increasing availability of information and awareness about medical tourism, more and more patients are considering MVT as an option for medical treatments.”

Dr Moopen added, “Our presence at the ‘Advantage Health Care-India’ summit reflects our dedication to co-creating a healthcare ecosystem where patients receive cutting-edge world-class treatment and unwavering support and empowerment throughout their illness to wellness journey. Aster Medcity, Kochi; Aster MIMS, Calicut, and Aster CMI in Bengaluru are today among the most trusted healthcare destinations for international patients. Aster continues to work closely with international governments, health ministries, medical institutions, and insurance companies, emphasizing excellent service delivery and a seamless patient experience. We will also soon be expanding our current services in GCC, SAARC, and African Countries and also enter CIS countries (Commonwealth of Independent States).”

Among the three flagship hospitals of Aster DM Healthcare India, namely Aster Medcity, Aster CMI & Aster MIMS Calicut, around 4000 international patients in IPD and more than 3600 patients in OPD were served in FY 22-23 from countries like Oman, the UAE, patients from East and West African countries, Middle East, and SAARC countries like Bangladesh, Maldives, Nepal and more collectively achieving more than 80cr revenue for Aster India business. Specialities that are most sought after are oncology, transplants (liver, kidney, bone marrow), neuro surgery, joint replacement and spine and cardiac and prostrate ailments.

At the Advantage Healthcare-India 2023, Dr Moopen co-chaired the session: Building a Continuum of Care: Integrated Healthcare for Holistic Wellbeing of the World, along with session chair G Kamala Vardhana Rao, Secretary to the Government of India & CEO, Food Safety and Standards Authority of India (FSSAI). The session, carefully curated by both Chairs, saw prominent names from the healthcare industry delve into critical aspects of the healthcare landscape, focusing on the seamless integration of healthcare services across the spectrum of patient needs.

Summing up the discussion, Dr Moopen expressed the importance of leveraging healthcare innovations, technologies like cloud-sharing and telemedicine, and secure data-sharing measures that can help build the MVT ecosystem in India.

Dr Moopen was also part of the esteemed CEO roundtable at the event, which saw participation and discussions among the leading healthcare leaders in India and government dignitaries.

Dr Nitish Shetty, CEO, Aster DM Healthcare, India, added, “The MVT sector in India is at a transformative juncture. With the convergence of quality medical treatments, affordable costs, and cutting-edge technology, India is poised to become a global hub for medical value travel. India’s advantage lies in the combination of quality medical treatments, affordability, trained medical professionals, and technology prowess. Our journey is aligned with the ‘Heal in India’ initiative, and we envision a future where patients from around the world seek exceptional medical care while experiencing India’s rich cultural heritage.”